MarketPulse
E

$EVAX

6 articles found
5 positive
0 negative
1 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Evaxion Consolidates Leadership, Promotes Rønø to Dual CSO-COO Role

Evaxion promotes Birgitte Rønø to combined Chief Scientific and Chief Operating Officer role to enhance platform communication and operational execution.
EVAXclinical-stageAI-Immunology platform
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Evaxion's AI Platform Unlocks Novel Antigen Source for Glioblastoma Vaccines

Evaxion's AI-Immunology platform identifies endogenous retroviruses as glioblastoma vaccine targets, addressing mutational burden challenges. Results presented at AACR in April 2026.
EVAXpersonalized medicinecancer immunotherapy
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Evaxion's Personalized Cancer Vaccine Shows 75% Response Rate in Extended Trial

Evaxion completes Phase 2 extension of personalized cancer vaccine EVX-01 with 75% response rate and 92% durability at two years.
MRKEVAXphase 2 trialimmunotherapy
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Evaxion Unveils AI-Designed Polio Vaccines at World Congress, Backed by Gates Foundation

Evaxion presents AI-designed polio vaccine concepts at World Vaccine Congress, partnering with Gates Foundation to advance next-generation immunology platform.
EVAXAI-Immunology platformvaccine development
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Evaxion Schedules 2026 AGM as AI-Powered Vaccine Pipeline Advances

Danish biotech $EVAX announces April 2026 Annual General Meeting in Copenhagen while advancing AI-driven cancer and infectious disease vaccines.
EVAXAnnual General Meetingclinical pipeline
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Evaxion to Report 2025 Results, Showcase AI-Immunology Platform Progress

Danish biotech $EVAX will announce full-year 2025 financial results and business update March 5, detailing AI-Immunology platform development across oncology, infectious disease, and autoimmune applications.
EVAXfinancial resultsclinical-stage